Longeveron

1. Laromestrocel DCM Ph2/3 start2H 2026Laromestrocel DCM Ph2/3 start, 2H 2026, routine
2. Laromestrocel HLHS Ph2b toplineSep 2026Laromestrocel HLHS Ph2b topline, Sep 2026, thesis-defining
3. Nasdaq Listing Compliance updateSep 21, 2026Nasdaq Listing Compliance update, Sep 21, 2026, routine
4. Laromestrocel HLHS BLA filing2027Laromestrocel HLHS BLA filing, 2027, material
5. Pediatric DCM Phase 2 registrational2027Pediatric DCM Phase 2 registrational, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.